Fundz

Zydus Lifesciences Appoints Christoph Stoller as President and Head of International Markets Business

RECENTLY ACQUIREDOct 31, 2026
New to company · from Glenmark Pharmaceuticals“Christoph Stoller joins Zydus from Glenmark Pharmaceuticals, where he served as President and Business Head for EMEA, LATAM, and APAC.”

Position

President

Company

Zydus Lifesciences

Christoph Stoller
Health CareMedical

Description

Zydus Lifesciences Limited has appointed Christoph Stoller as President and Business Unit Head for its International Markets Business, effective November 2, 2026. This appointment follows the resignation of Dr. Amrut Naik, who held the same position

Who to call at Zydus Lifesciences, and when

A new leader at Zydus Lifesciences brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Zydus Lifesciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Zydus Lifesciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Zydus Lifesciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Zydus Lifesciences

About

After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. Our legacy of over 70 years in healthcare and being dedicated to life in all its dimensions is reaffirmed in our new mission, vision and purpose. Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Lifesciences Ltd. Zydus has always been a purpose driven company. It has been our legacy of keeping patients and caregivers at the heart of everything we do. Backed by innovation, we have been exploring novel approaches in healthcare. As we continue to make a meaningful difference in the lives of patients, we hope to empower them and help them lead  healthier and more fulfilled lives.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Zydus Lifesciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Zydus Lifesciences's next move

Learn about Strategic plan

Zydus Lifesciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.